Logo image
Successful treatment of macrophage activation syndrome complicating adult Still disease with anakinra
Journal article   Peer reviewed

Successful treatment of macrophage activation syndrome complicating adult Still disease with anakinra

N.K. Loh, M. Lucas, S. Fernandez and D. Prentice
Internal Medicine Journal, Vol.42(12), pp.1358-1362
2012
url
Link to Published Version *Subscription may be requiredView

Abstract

A previously healthy 20-year-old man presented with adult Still disease (ASD). He developed life-threatening macrophage activation syndrome (MAS), which was refractory to standard immunosuppression but responded dramatically to the IL-1 receptor antagonist anakinra. Subsequent immunological investigations included assessment of the perforin expression of natural killer (NK) cells and CD8+ T cells, which confirmed MAS.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.106 Rheumatology
1.106.1646 Juvenile Arthritis & HLH
Web Of Science research areas
Rheumatology
ESI research areas
Clinical Medicine
Logo image